South African researchers have unveiled a game-changing handheld device that detects tuberculosis (TB) in 30 minutes using just a drop of blood – no sputum samples or lab delays required. 💡 This innovation could save millions in high-risk regions where TB remains a top killer, claiming over 1.2 million lives globally in 2024 alone.
🔬 Traditional tests force patients to cough up infectious mucus, risking exposure to healthcare workers and others. The new MARTI device instead analyzes blood for antibodies signaling active infections. "You’re not aerosolizing TB bacteria into the air," explains Carl Baumeister of MARTI TB Diagnostics. "It’s safer and faster – like a COVID test for TB."
🚀 The tool targets undiagnosed cases driving TB’s spread, particularly in prisons and mines. Professor Jan Verschoor notes: "20% of TB deaths occur before diagnosis. This device flips the script." With TB costing billions in lost productivity annually, rapid detection could boost both public health and economies.
🌍 Next steps? Scaling production for global use by late 2026. For young innovators and health advocates, this is tech that truly #ChangesTheGame.
